B
Bioretec Oy
OMXH:BRETEC
Bioretec Oy
OMXH:BRETEC
Price:
0.033
EUR
-8.84%
Market Closed
Market Cap:
€57.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bioretec Oy
OMXH:BRETEC
|
FI |
|
S
|
Savimex Corp
VN:SAV
|
VN |
|
L3harris Technologies Inc
NYSE:LHX
|
US |
|
T
|
TMC Life Sciences Bhd
KLSE:TMCLIFE
|
MY |
|
W
|
Wuzhou Special Paper Group Co Ltd
SSE:605007
|
CN |
|
United Overseas Bank Ltd
SGX:U11
|
SG |
|
Eprint Group Ltd
HKEX:1884
|
HK |
|
Cochlear Ltd
ASX:COH
|
AU |
|
Axos Financial Inc
NYSE:AX
|
US |
|
Kokuyo Co Ltd
TSE:7984
|
JP |
|
S
|
Sankyu Inc
TSE:9065
|
JP |
|
NuGene International Inc
OTC:NUGN
|
US |
|
S
|
Shenzhen Xinyichang Technology Co Ltd
SSE:688383
|
CN |
|
LK Technology Holdings Ltd
HKEX:558
|
HK |
|
Rheinmetall AG
XETRA:RHM
|
DE |
|
PlayAGS Inc
NYSE:AGS
|
US |
Balance Sheet
Balance Sheet Decomposition
Bioretec Oy
Bioretec Oy
Balance Sheet Decomposition is not available for
Bioretec Oy
Bioretec Oy
Balance Sheet
Bioretec Oy
Bioretec Oy
Currency: EUR
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
1
|
0
|
2
|
7
|
1
|
7
|
6
|
4
|
|
| Cash Equivalents |
1
|
0
|
2
|
7
|
1
|
7
|
6
|
4
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
0
|
1
|
1
|
1
|
1
|
2
|
4
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
1
|
3
|
8
|
3
|
9
|
10
|
9
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
2
-34%
|
4
+138%
|
9
+120%
|
3
-59%
|
11
+206%
|
11
+8%
|
12
+2%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
2
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
1
|
4
|
1
|
2
|
1
|
2
|
|
| Long-Term Debt |
2
|
2
|
2
|
0
|
1
|
1
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
3
+19%
|
3
-13%
|
4
+68%
|
2
-63%
|
2
+55%
|
2
-28%
|
2
+10%
|
|
| Equity | |||||||||
| Common Stock |
9
|
9
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Retained Earnings |
9
|
10
|
3
|
1
|
2
|
4
|
6
|
6
|
|
| Other Equity |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
1
N/A
|
1
N/A
|
4
+219%
|
2
-56%
|
8
+328%
|
10
+18%
|
10
+0%
|
|
| Total Liabilities & Equity |
2
N/A
|
2
-34%
|
4
+138%
|
9
+120%
|
3
-59%
|
11
+206%
|
11
+8%
|
12
+2%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
13
|
13
|
13
|
14
|
15
|
222
|
265
|
335
|
|
Switch to:
Switch to:
See Also
Discover More
